Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ABIVAX Société AnonymeADS(ABVX) | 1,804,703 | 2,050,822 | +246,119 | $240.49M | $203.07M | 8.71% | -$37.42M |
| State Street SPDR S&P 500 ETF TrustTR UNIT(SPY) | 129,087 | 177,624 | +48,537 | $96.40M | $135.46M | 5.81% | +$39.06M |
| Protagonist Therapeutics Inc | 960,863 | 951,403 | -9,460 | $117.78M | $134.04M | 5.75% | +$16.26M |
| Roivant Sciences Ltd.SHS(ROIV) | 3,157,008 | 3,079,526 | -77,482 | $111.73M | $112.62M | 4.83% | +$891.8K |
| Zai Lab LimitedADR(ZLAB) | 3,369,034 | 3,381,364 | +12,330 | $64.01M | $89.07M | 3.82% | +$25.05M |
| Immunovant, Inc.(IMVT) | 2,330,716 | 2,115,502 | -215,214 | $89.80M | $71.46M | 3.06% | -$18.34M |
| Xenon Pharmaceuticals Inc.(XENE) | 166,550 | 1,162,029 | +995,479 | $10.05M | $43.22M | 1.85% | +$33.16M |
| Denali Therapeutics Inc.(DNLI) | 1,029,080 | 2,072,050 | +1,042,970 | $26.47M | $42.83M | 1.84% | +$16.36M |
| Ea Series TrustALPHA ARCH 1 3 ALPHA ARCH 1-3 | 337,125 | 337,125 | 0 | $39.47M | $39.91M | 1.71% | +$438.3K |
| Septerna, Inc.(SEPN) | 940,747 | 974,396 | +33,649 | $31.51M | $38.13M | 1.63% | +$6.62M |
| Agios Pharmaceuticals, Inc.(AGIO) | 1,288,053 | 1,139,464 | -148,589 | $47.80M | $37.89M | 1.62% | -$9.91M |
| Aura Biosciences Inc | 130,152 | 5,385,879 | +5,255,727 | $924.1K | $33.82M | 1.45% | +$32.90M |
| Viking Therapeutics, Inc.(VKTX) | 574,038 | 1,034,749 | +460,711 | $22.39M | $33.73M | 1.45% | +$11.34M |
| Cytokinetics, Incorporated(CYTK) | 457,907 | 461,407 | +3,500 | $39.01M | $30.41M | 1.30% | -$8.60M |
| Insmed Incorporated(INSM) | 228,520 | 229,531 | +1,011 | $24.36M | $26.20M | 1.12% | +$1.83M |
| Freenome Inc | 0 | 1,645,800 | +1,645,800 | $0 | $25.92M | 1.11% | +$25.92M |
| Celldex Therapeutics, Inc.(CLDX) | 619,542 | 799,304 | +179,762 | $23.05M | $25.91M | 1.11% | +$2.85M |
| Anteris Technologies Global | 3,145,096 | 3,237,321 | +92,225 | $30.98M | $25.15M | 1.08% | -$5.83M |
| BridgeBio Pharma, Inc.(BBIO) | 176,689 | 379,261 | +202,572 | $13.16M | $24.96M | 1.07% | +$11.80M |
| Praxis Precision Medicines, Inc.(PRAX) | 74,253 | 84,751 | +10,498 | $24.86M | $24.68M | 1.06% | -$177.1K |
| Fulcrum Therapeutics Inc | 1,565,029 | 6,648,027 | +5,082,998 | $5.73M | $24.60M | 1.05% | +$18.87M |
| Vir Biotechnology, Inc.(VIR) | 2,456,677 | 2,158,839 | -297,838 | $25.03M | $24.14M | 1.03% | -$897.7K |
| Dbv Technologies S AADS | 528,295 | 2,010,831 | +1,482,536 | $8.66M | $23.65M | 1.01% | +$14.98M |
| Enanta Pharmaceuticals Inc | 1,344,510 | 1,733,320 | +388,810 | $19.60M | $22.85M | 0.98% | +$3.24M |
| Editas Medicine Inc | 8,889,000 | 8,889,000 | 0 | $28.80M | $22.84M | 0.98% | -$5.96M |
| Spyre Therapeutics, Inc.(SYRE) | 283,982 | 237,567 | -46,415 | $25.21M | $21.15M | 0.91% | -$4.06M |
| Enliven Therapeutics Inc | 387,718 | 442,682 | +54,964 | $19.68M | $20.29M | 0.87% | +$615.9K |
| Nurix Therapeutics, Inc.(NRIX) | 313,236 | 813,236 | +500,000 | $7.60M | $19.28M | 0.83% | +$11.68M |
| SanofiADR(SNY) | 57,100 | 464,600 | +407,500 | $2.44M | $19.16M | 0.82% | +$16.72M |
| Revolution Medicines, Inc.(RVMD) | 87,509 | 87,509 | 0 | $16.39M | $17.96M | 0.77% | +$1.57M |
| Sarepta Therapeutics, Inc.(SRPT) | 730,649 | 952,063 | +221,414 | $13.13M | $17.35M | 0.74% | +$4.22M |
| Maze Therapeutics, Inc.(MAZE) | 339,276 | 637,353 | +298,077 | $10.12M | $17.32M | 0.74% | +$7.20M |
| Adlai Nortye Group LtdADS | 1,017,805 | 997,356 | -20,449 | $11.70M | $15.96M | 0.68% | +$4.25M |
| Rallybio Corp | 926,352 | 926,352 | 0 | $14.82M | $15.93M | 0.68% | +$1.11M |
| Nektar Therapeutics(NKTR) | 244,184 | 258,182 | +13,998 | $17.05M | $15.63M | 0.67% | -$1.41M |
| UroGen Pharma Ltd.(URGN) | 252,395 | 369,785 | +117,390 | $9.29M | $15.02M | 0.64% | +$5.74M |
| Taysha Gene Therapies, Inc.(TSHA) | 3,040,466 | 3,059,567 | +19,101 | $20.71M | $14.90M | 0.64% | -$5.81M |
| Monopar Therapeutics Inc | 217,595 | 179,032 | -38,563 | $20.15M | $14.26M | 0.61% | -$5.88M |
| Janux Therapeutics Inc | 420,881 | 823,876 | +402,995 | $6.46M | $14.24M | 0.61% | +$7.77M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 136,158 | 138,658 | +2,500 | $15.12M | $13.20M | 0.57% | -$1.92M |
| Prothena Corp PlcSHS SHS | 1,554,535 | 1,522,103 | -32,432 | $15.22M | $12.76M | 0.55% | -$2.46M |
| Cogent Biosciences, Inc.(COGT) | 12,200 | 392,422 | +380,222 | $472.1K | $12.57M | 0.54% | +$12.09M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 22,208 | 16,446 | -5,762 | $13.85M | $12.47M | 0.53% | -$1.38M |
| Spdr Series TrustST STR BLO 1 ETF ST STR BLO 1 ETF | 135,585 | 135,585 | 0 | $12.43M | $12.43M | 0.53% | $0 |
| Tenax Therapeutics Inc | 220,462 | 6,524,151 | +6,303,689 | $3.21M | $12.33M | 0.53% | +$9.12M |
| Monte Rosa Therapeutics Inc | 216,752 | 1,007,752 | +791,000 | $5.25M | $12.02M | 0.52% | +$6.78M |
| AbCellera Biologics Inc.(ABCL) | 0 | 822,163 | +822,163 | $0 | $12.00M | 0.51% | +$12.00M |
| Establishment Labs Holdings Inc.(ESTA) | 185,619 | 185,619 | 0 | $15.93M | $11.91M | 0.51% | -$4.02M |
| Vogenx Inc | 0 | 522,175 | +522,175 | $0 | $11.90M | 0.51% | +$11.90M |
| Inhibikase Therapeutics Inc | 7,387,205 | 5,708,755 | -1,678,450 | $15.00M | $11.73M | 0.50% | -$3.26M |
| Ovid Therapeutics Inc | 7,417,479 | 4,560,813 | -2,856,666 | $19.95M | $11.36M | 0.49% | -$8.60M |
| Avalyn Pharmaceuticals Inc | 146,447 | 397,719 | +251,272 | $4.82M | $11.33M | 0.49% | +$6.51M |
| Teva Pharmaceutical Inds LtdSHS | 0 | 276,348 | +276,348 | $0 | $10.94M | 0.47% | +$10.94M |
| Xencor, Inc.(XNCR) | 232,560 | 433,807 | +201,247 | $3.74M | $10.82M | 0.46% | +$7.08M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 494,378 | 366,968 | -127,410 | $8.88M | $10.68M | 0.46% | +$1.80M |
| Helix Acquisition Corp IiiCL A | 1,000,000 | 1,000,000 | 0 | $10.60M | $10.52M | 0.45% | -$80.0K |
| Zentalis Pharmaceuticals Inc | 652,750 | 3,762,532 | +3,109,782 | $3.17M | $10.42M | 0.45% | +$7.26M |
| Beam Therapeutics Inc.(BEAM) | 0 | 420,981 | +420,981 | $0 | $10.29M | 0.44% | +$10.29M |
| Vor Biopharma Inc.(VOR) | 680,626 | 531,349 | -149,277 | $12.53M | $10.14M | 0.43% | -$2.39M |
| Viking Therapeutics IncNOTE 2 000 10 1 | 0 | 0 | 0 | $0 | $9.95M | 0.43% | +$9.95M |
| Edgewise Therapeutics, Inc.(EWTX) | 143,199 | 243,199 | +100,000 | $5.82M | $9.87M | 0.42% | +$4.06M |
| Kazia Therapeutics LtdADS | 61,550 | 967,740 | +906,190 | $866.6K | $9.29M | 0.40% | +$8.42M |
| Climb Bio Inc | 822,649 | 792,936 | -29,713 | $10.73M | $9.09M | 0.39% | -$1.63M |
| Replimune Group, Inc.(REPL) | 655,784 | 655,784 | 0 | $7.26M | $8.68M | 0.37% | +$1.42M |
| Opus Genetics Inc | 1,783,781 | 1,783,781 | 0 | $7.33M | $8.63M | 0.37% | +$1.30M |
| Summit Therapeutics Inc.(SMMT) | 191,869 | 496,965 | +305,096 | $2.80M | $8.40M | 0.36% | +$5.61M |
| Vaxcyte, Inc.(PCVX) | 146,034 | 146,034 | 0 | $8.49M | $8.31M | 0.36% | -$179.6K |
| Research Alliance Corp IiiCL A | 650,000 | 767,000 | +117,000 | $6.96M | $8.31M | 0.36% | +$1.35M |
| Amanat Acquisition CorpCL A | 750,000 | 750,000 | 0 | $7.62M | $7.99M | 0.34% | +$367.5K |
| Entera Bio LtdSHS | 0 | 2,625,980 | +2,625,980 | $0 | $7.64M | 0.33% | +$7.64M |
| Inventiva SaADS | 3,606,656 | 2,066,330 | -1,540,326 | $13.63M | $7.62M | 0.33% | -$6.01M |
| Jatt Ii Acquisition Corp | 417,724 | 683,022 | +265,298 | $4.75M | $7.60M | 0.33% | +$2.85M |
| Ionis Pharmaceuticals, Inc.(IONS) | 166,286 | 169,593 | +3,307 | $13.18M | $7.57M | 0.32% | -$5.61M |
| Rainier Acquisition CorpUNIT 08 24 2031 | 0 | 742,500 | +742,500 | $0 | $7.55M | 0.32% | +$7.55M |
| C4 Therapeutics Inc | 291,957 | 2,232,857 | +1,940,900 | $1.36M | $7.44M | 0.32% | +$6.07M |
| Maplight Therapeutics Inc | 26,497 | 725,165 | +698,668 | $949.7K | $7.39M | 0.32% | +$6.44M |
| Savara Inc.(SVRA) | 1,403,409 | 1,410,409 | +7,000 | $8.64M | $7.28M | 0.31% | -$1.37M |
| Perspective Therapeutics Inc | 1,210,117 | 2,617,870 | +1,407,753 | $4.13M | $7.20M | 0.31% | +$3.07M |
| Silence Therapeutics plcADS(SLN) | 338,373 | 629,654 | +291,281 | $3.72M | $6.88M | 0.30% | +$3.17M |
| Biohaven Ltd.(BHVN) | 501,687 | 501,687 | 0 | $7.47M | $6.70M | 0.29% | -$767.6K |
| Ascendis Pharma A/S(ASND) | 28,604 | 28,604 | 0 | $7.63M | $6.52M | 0.28% | -$1.11M |
| Destiny Tech100 Inc.(DXYZ) | 0 | 210,399 | +210,399 | $0 | $6.49M | 0.28% | +$6.49M |
| Yarrow Bioscience Inc | 0 | 282,996 | +282,996 | $0 | $6.37M | 0.27% | +$6.37M |
| Tcgx Acquisition CorpCL A | 0 | 500,374 | +500,374 | $0 | $6.26M | 0.27% | +$6.26M |
| Research Alliance Corp IvCL A | 0 | 525,234 | +525,234 | $0 | $6.22M | 0.27% | +$6.22M |
| Onkure Therapeutics IncCL A | 2,238,684 | 2,238,684 | 0 | $10.21M | $6.10M | 0.26% | -$4.11M |
| Cytomx Therapeutics Inc. | 3,365,118 | 2,204,454 | -1,160,664 | $12.62M | $6.00M | 0.26% | -$6.62M |
| Damora Therapeutics Inc | 0 | 281,000 | +281,000 | $0 | $5.98M | 0.26% | +$5.98M |
| Pliant Therapeutics Inc | 5,509,724 | 5,509,724 | 0 | $6.28M | $5.95M | 0.26% | -$330.6K |
| Mineralys Therapeutics, Inc.(MLYS) | 298,886 | 227,294 | -71,592 | $8.06M | $5.71M | 0.24% | -$2.35M |
| Oaktree Acquisition Corp IiiUNIT 10 04 2029 UNIT 10/04/2029 | 516,482 | 516,482 | 0 | $5.60M | $5.62M | 0.24% | +$25.8K |
| Equillium Inc | 3,758,569 | 3,446,539 | -312,030 | $12.03M | $5.60M | 0.24% | -$6.43M |
| uniQure N.V.SHS(QURE) | 324,672 | 230,814 | -93,858 | $14.95M | $5.58M | 0.24% | -$9.38M |
| Biogen Inc.(BIIB) | 17,900 | 24,400 | +6,500 | $3.87M | $5.51M | 0.24% | +$1.64M |
| Krystal Biotech, Inc.(KRYS) | 16,420 | 16,420 | 0 | $6.10M | $5.46M | 0.23% | -$642.2K |
| Inflarx Nv | 3,000,000 | 3,000,000 | 0 | $6.72M | $5.40M | 0.23% | -$1.32M |
| Korro Bio Inc | 540,054 | 540,054 | 0 | $7.12M | $5.35M | 0.23% | -$1.77M |
| Lexeo Therapeutics Inc | 1,565,950 | 1,576,796 | +10,846 | $7.29M | $5.33M | 0.23% | -$1.96M |
| Contineum Therapeutics IncCL A | 278,961 | 384,890 | +105,929 | $4.57M | $5.17M | 0.22% | +$593.1K |
| Ardelyx Inc | 11,000 | 1,492,000 | +1,481,000 | $56.1K | $5.10M | 0.22% | +$5.05M |